- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03504735
Caduet and TLC Intervention in Metabolic Syndrome
Effect of Caduet and TLC Intervention on Metabolic Parameters
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Single center, investigator driven, double blinded, randomized with Caduet 5/10mg vs placebo. The participants visited with investigators on a monthly bases to evaluate the BP, weight, and obtain the waist measurements, and counseling. OGTT was performed at the beginning and the end of the study. Lipid and glucose parameters were measured 5 times in duration of the study period.
Exercise physiologists and dietitians completed the baseline evaluations and provided recommendations throughout the study period in person, via phone or e-mail: per subject preference. VO2 max was measured at the beginning and end of the study. Pedometers dispensed to encourage physical activity.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BP ≥130/85
- Metabolic syndrome per NCEP-ATP III revised (3/5 criteria)
- Men and women age 40-65
Exclusion Criteria:
- Inability to sign a consent form.
- Unwillingness to complete the protocol for the duration of 15 months
- Unwillingness of primary care physician to participate in the program
- Patients already on hypercholesterolemia agent
- Fasting plasma glucose above 126 mg/dL or current treatment for diabetes.
- If the physician believes the patient should be started on antihypertensive regimen.
- Creatinine clearance <50ml/min.
- Therapy with anticoagulants
- Pregnant/lactating women (pre-menopausal women should be on birth control pill)
- AST/ALT > x3 upper limit of normal
- Evidence of cholelithiasis
- Use of oral anticoagulants
- Cancer
- Recent cardiovascular event (<6months)
- Substance abuse
- Since there is no translator, non-English speaking subjects will not be enrolled in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Therapeutic Lifestyle Change+Placebo
Therapeutic Life-style change intervention with Placebo pills.
|
Monthly consult with a dietitian and fitness instructor.
Other Names:
Take once daily.
Other Names:
|
Active Comparator: Therapeutic Lifestyle Change+Caduet
Therapeutic Lifestyle Change intervention with Caduet pills.
|
Monthly consult with a dietitian and fitness instructor.
Other Names:
Take once daily.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Resolution or improvement of metabolic syndrome.
Time Frame: 12 months
|
HDL >40mg/dl for men, >50 mg/dl for women.
Glucose <100mg/dl Waist circumference <40 in in men, <35 in in women Triglycerides <150mg/dl BP <130/80 Attainment of 1 or more of these goals will result in resolution or improvement of metabolic syndrome
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight loss
Time Frame: 12 months
|
5% decrease compared to that at the start of the study.
|
12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Nicola Abate, MD, University of Texas
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Glucose Metabolism Disorders
- Metabolic Diseases
- Disease
- Insulin Resistance
- Hyperinsulinism
- Syndrome
- Metabolic Syndrome
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Antihypertensive Agents
- Enzyme Inhibitors
- Antimetabolites
- Anticholesteremic Agents
- Hypolipidemic Agents
- Lipid Regulating Agents
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Membrane Transport Modulators
- Calcium-Regulating Hormones and Agents
- Calcium Channel Blockers
- Amlodipine, atorvastatin drug combination
Other Study ID Numbers
- 082005-005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Syndrome
-
Universidad de los Andes, ChileCompleted
-
SanofiBristol-Myers SquibbCompletedMetabolic Syndrome xUnited States
-
Mayo ClinicCompleted
-
The Catholic University of KoreaCompletedMetabolic Syndrome X | Metabolic Cardiovascular Syndrome | Insulin Resistance Syndrome X | Dysmetabolic Syndrome XKorea, Republic of
-
Taipei Medical University WanFang HospitalUnknownMetabolic Cardiovascular SyndromeTaiwan
-
Cairo UniversityCompletedMetabolic Syndrome in WomenEgypt
-
Andalas UniversityHasanuddin University; Universitas Sumatera UtaraCompletedMetabolic Syndrome, Protection AgainstIndonesia
-
Azienda Ospedaliera Specializzata in Gastroenterologia...Active, not recruiting
-
Assiut UniversityUnknownMetabolic Syndrome, Protection Against
-
Charite University, Berlin, GermanyRecruitingMetabolic Syndrome, Protection AgainstGermany
Clinical Trials on Therapeutic Lifestyle Change
-
Yonsei UniversityRecruitingVaricose Veins of Lower LimbKorea, Republic of
-
Scripps Center for Integrative MedicineUnknown
-
Dokuz Eylul UniversityNot yet recruitingPolycystic Ovary Syndrome
-
California Polytechnic State University-San Luis...The Miriam Hospital; Bradley HospitalRecruitingObesity | Diet, Healthy | Inactivity, PhysicalUnited States
-
University of British ColumbiaUnknown
-
Cairo UniversityRecruitingDry Eye | Diet Habit | Physical InactivityEgypt
-
University of Modena and Reggio EmiliaUnknownExercise Addiction | Maternal Obesity Complicating Pregnancy | High-Risk Pregnancy | Inflammatory Status During Preganancy | Maternal Body CompositionItaly
-
Northumbria UniversityRecruitingPeripheral Arterial Disease | Intermittent Claudication | Behavior, Health | Exercise InterventionUnited Kingdom
-
Wageningen UniversityRijnstate Hospital; Flevoziekenhuis; Deventer Ziekenhuis; World Cancer Research... and other collaboratorsActive, not recruitingColorectal Cancer | Rectal Cancer | Colon Cancer | Cancer-related FatigueNetherlands